Salesforce has entered an alliance with QuintilesIMS’ aimed at helping life sciences companies move treatments from clinical phases to commercial applications more effectively.
QuintilesIMS, formed last year through the merger of healthcare data provider IMS Health and medical research firm Quintiles Transnational, is one of the world’s largest integrated healthcare services companies. The combined entity has 50,000 employees in 100 different countries.
QuintilesIMS plans to use the Salesforce Platform’s cloud, mobile, social and artificial intelligence capabilities to build new solutions to bring therapies to market.
Quintiles initially plans to use Salesforce to help manage clinical trials, patient recruitment, marketing and other functions, according to Quintiles spokesperson Tor Constantino.
For example, the companies will work together on ways to improve the feasibility of clinical trials, improve patient enrollment and communications, and help mitigate delays, he told CRM Buyer.
Over the long term, Quintiles plans to work with Salesforce on items like digital health, patient engagement and precision management, according to Constantino.
Salesforce has worked with Quintiles for more than a decade, dating back to 2004, when it inked a deal to provide CRM software for more than 2,000 users at Quintiles Transnational.
The alliance will help QuintilesIMS “create solutions that empower life sciences firms to collaborate with providers and patients in smarter and more predictive ways throughout the clinical life cycle,” said Salesforce COO Keith Block.
The deal represents “transformative potential for the life sciences industry,…